The Semisynthetic Product of Lysergic Acid Diethylamide

Despite LSD’s successful and safe use as a psychotherapeutic adjunct and experimental tool (cf. Ref. [7] and the retrospective surveys of Cohen [8] and Malleson [9]), almost no legal clinical research with LSD has occurred since the 1970s. Exceptions include the continued use in psychotherapy by Hanscarl Leuner at Göttingen University (Germany) and by a […]

The Semisynthetic Product of Lysergic Acid Diethylamide Read More »

Analytical Use of Innovative Chemistry

The chemical industry is a crucial enabler for solving these challenges, but doing so will require reinventing its approach to innovation. That means a fundamental change in the processes, organization and capabilities of today’s chemical company. For example, a shift from: To achieve the UN Sustainable Development Goals, the chemical industry requires innovation. For example,

Analytical Use of Innovative Chemistry Read More »

The Risks of Novel Psychoactive Chemicals

Commerce in these substances occupies a legal gray area (2). In Germany, drugs for human use are regulated on the national level by the Medicinal Products Act (Arzneimittelgesetz, AMG) and the Narcotics Act (Betäubungsmittelgesetz, BtMG). To evade legal restrictions, NPS are mislabeled as “research chemicals,” “herbal incense,” or “bath salts” that are “not for human

The Risks of Novel Psychoactive Chemicals Read More »

Legal and Regulatory Processes of Research Chemicals

Research chemicals are commonly classified as synthetic drugs for legal and regulatory purposes. Synthetics are a broad grouping of drugs which include MDMA (ecstasy), ketamine, synthetic cathinones (bath salts), and synthetic cannabinoids (Spice and K2). Many agencies refer to these drugs as new psychoactive substances (NPS), as they are all manufactured in laboratory settings, and many

Legal and Regulatory Processes of Research Chemicals Read More »

Shopping Cart